Advertisement
Research ArticleArticle

Characterization of Binding Properties to Human P-Glycoprotein: Development of a [3H]Verapamil Radioligand-Binding Assay

Stephan Döppenschmitt, Peter Langguth, Carl Gunnar Regårdh, Tommy B. Andersson, Constanze Hilgendorf and Hildegard Spahn-Langguth
Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 348-357;

Article Information

vol. 288 no. 1 348-357
PubMed 
9862789
Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Received February 20, 1998
  • Accepted July 20, 1998
  • Published online January 1, 1999.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Stephan Döppenschmitt1,2,
  2. Peter Langguth2,3,
  3. Carl Gunnar Regårdh2,
  4. Tommy B. Andersson2,
  5. Constanze Hilgendorf1 and
  6. Hildegard Spahn-Langguth1
  1. 1School of Pharmacy, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany (S.D., C.H., H.S.-L.); 2Astra Hässle AB, Mölndal, Sweden (S.D., P.L., C.G.R., T.B.A.); and 3School of Pharmacy, Johannes Gutenberg University, Mainz, Germany (P.L.)
    View Full Text

    Statistics from Altmetric.com

    Article usage

    Article usage:

    No statistics are available.

    Back to top

    In this issue

    Download PDF
    Article Alerts
    Email Article
    Citation Tools

    Research ArticleArticle

    Characterization of Binding Properties to Human P-Glycoprotein: Development of a [3H]Verapamil Radioligand-Binding Assay

    Stephan Döppenschmitt, Peter Langguth, Carl Gunnar Regårdh, Tommy B. Andersson, Constanze Hilgendorf and Hildegard Spahn-Langguth
    Journal of Pharmacology and Experimental Therapeutics January 1, 1999, 288 (1) 348-357;
    del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo

    Jump to section

    Advertisement